DIACOMIT

This brand name is authorized in Austria, Australia, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Japan, Lithuania, Netherlands, Poland, Romania, United Kingdom, United States, South Africa

Active ingredients

The drug DIACOMIT contains one active pharmaceutical ingredient (API):

1 Stiripentol UNII R02XOT8V8I - STIRIPENTOL

Stiripentol potentiates the efficacy of other anticonvulsants, such as carbamazepine, sodium valproate, phenytoin, phenobarbital and many benzodiazepines, as the result of pharmacokinetic interactions. The second effect of stiripentol is mainly based on metabolic inhibition of several isoenzymes, in particular CYP450 3A4 and 2C19, involved in the hepatic metabolism of other anti-epileptic medicines. Read about Stiripentol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DIACOMIT Hard capsule	European Medicines Agency (EU)	MPI, EU: SmPC
DIACOMIT Capsule / Powder for suspension	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N03AX17	Stiripentol	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AX Other antiepileptics
Discover more medicines within N03AX17

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 12088F, 12103B, 12106E, 12107F
Country: CA	Health Products and Food Branch	Identifier(s): 02398958, 02398966, 02398974
Country: EE	Ravimiamet	Identifier(s): 1280045, 1280056, 1280067, 1280078, 1280089, 1280090, 1280102, 1280113, 1280124, 1280135, 1280146, 1280157, 1848944, 1848955, 1848966
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 06367002, 06367005, 06367008, 06367011
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 029596, 029608, 029619, 029630
Country: FR	Base de données publique des médicaments	Identifier(s): 61501691, 63431170, 64809018, 69581821
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 134030, 134033, 134038, 134043
Country: JP	医薬品医療機器総合機構	Identifier(s): 1139011M1028, 1139011R1025, 1139011R2021
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1027928, 1027929, 1027930, 1027931, 1027932, 1027933, 1027934, 1027935, 1027936, 1027937, 1027938, 1027939, 1092749
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 88560, 88579, 88587, 88595
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100172979, 100172991, 100173000, 100173022, 100458903
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W51468001, W51468002, W51468003, W51470001, W51470002, W51470003, W51471001, W51471002, W51471003, W58592001, W58592002, W58592003
Country: US	FDA, National Drug Code	Identifier(s): 68418-7939, 68418-7940, 68418-7941, 68418-7942
Country: ZA	Health Products Regulatory Authority	Identifier(s): 55/2.5/0281, 55/2.5/0282, 55/2.5/0283, 55/2.5/0284